BACKGROUND
Influenza B vaccine effectiveness (VE) has varied by season, lineage, antigenic drift, and vaccine composition. After B/Yamagata detection ceased globally, trivalent vaccines containing B/Victoria were reintroduced in 2024-25. We evaluated influenza B circulation and VE across eight analyzed seasons spanning...
J. Meeker, Ashley M. Price, Emily T. Martin et al.· Journal of Infectious Diseas...· 0 citations
Rapid, portable detection of multiple nucleic acid targets is essential for infectious disease surveillance and precision oncology. CRISPR-based diagnostics have set a high bar for sensitivity and single-base specificity, yet their reliance on collateral nuclease activity complicates multiplexing, integration with ampl...
Padric M. Garden, Yu-Dan Li, V. Murugan et al.· ACS Sensors· 0 citations
Background: Recombinant (RIV) and cell culture-based inactivated (ccIIV) influenza vaccines could improve seasonal influenza prevention; however, evidence is limited in how protection may differ among non-egg-based vaccines. Methods: We conducted a randomized trial of RIV versus ccIIV to compare vaccine immunogenicity...
Kelsey M. Sumner, Emma K. Noble, Lauren Grant et al.· medRxiv· 0 citations
During the 2023-24 and 2024-25 RSV seasons, unpaired nasopharyngeal swab specimens from patients presenting to Arizona healthcare systems with symptoms of influenza-like illness were collected to perform phylogenetic and genomic analyses to classify RSV genomes and detect mutations in the antigenic sites of the F prote...
S. C. Holland, L. Holland, T. Porter et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.